AEGON Asset Management (UK)’s Edwards Lifesciences EW Stock Holding History

AEGON Asset Management (UK)’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$4K	Hold	45	–	–	﹤0.01%	156
2023 Q1	$4K	Buy	45 +6	+15%	+$472	﹤0.01%	158
2022 Q4	$3K	Sell	39 -16,588	-100%	-$1.28M	﹤0.01%	161
2022 Q3	$1.38M	Buy	16,627 +16,588	+42,533%	+$1.6M	0.03%	141
2022 Q2	$4K	Buy	+39	New	+$4.04K	﹤0.01%	167
2020 Q3	–	Sell	-35,337	Closed	-$2.44M	–	152
2020 Q2	$2.44M	Hold	35,337	–	–	0.05%	110
2020 Q1	$2.22M	Hold	35,337	–	–	0.06%	102
2019 Q4	$2.75M	Hold	35,337	–	–	0.07%	111
2019 Q3	$2.59M	Hold	35,337	–	–	0.07%	104
2019 Q2	$2.18M	Hold	35,337	–	–	0.06%	108
2019 Q1	$2.25M	Hold	35,337	–	–	0.06%	96
2018 Q4	$1.8M	Sell	35,337 -11,154	-24%	-$564K	0.06%	103
2018 Q3	$2.7M	Hold	46,491	–	–	0.06%	97
2018 Q2	$2.26M	Hold	46,491	–	–	0.06%	106
2018 Q1	$2.16M	Sell	46,491 -8,181	-15%	-$355K	0.06%	112
2017 Q4	$2.05M	Hold	54,672	–	–	0.05%	113
2017 Q3	$1.99M	Buy	54,672 +20,631	+61%	+$787K	0.05%	106
2017 Q2	$1.34M	Sell	34,041 -1,041	-3%	-$38K	0.04%	130
2017 Q1	$1.1M	Sell	35,082 -552	-2%	-$17.3K	0.03%	166
2016 Q4	$1.11M	Sell	35,634 -1,884	-5%	-$61K	0.03%	150
2016 Q3	$1.51M	Buy	+37,518	New	+$1.41M	0.04%	113
2015 Q2	–	Sell	-64,074	Closed	-$1.52M	–	193
2015 Q1	$1.52M	Buy	+64,074	New	+$1.44M	0.04%	131

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

AEGON Asset Management (UK)'s EW Position: Q2 2023 in Review

AEGON Asset Management (UK) held its Edwards Lifesciences (EW) position steady in Q2 2023 at 45 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #156.

AEGON Asset Management (UK) first reported a position in EW in Q1 2015 and has held it in 22 quarters since. The position peaked at $2.75M in Q4 2019. 1,279 funds tracked by Wall St. Rank hold EW as of Q2 2023.

AEGON Asset Management (UK) held 45 shares of Edwards Lifesciences worth $4K as of Q2 2023.
AEGON Asset Management (UK) left its Edwards Lifesciences share count unchanged in Q2 2023.
Edwards Lifesciences made up ﹤0.01% of AEGON Asset Management (UK)'s portfolio in Q2 2023, its #156 holding.
AEGON Asset Management (UK) first reported a position in Edwards Lifesciences in Q1 2015 and has held it in 22 quarters since.
AEGON Asset Management (UK)'s Edwards Lifesciences position peaked at $2.75M in Q4 2019.
1,279 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2023.

Based on AEGON Asset Management (UK)'s 13F filing for Q2 2023, filed 28 Jul 2023.